Liabilities and Equity in USD of IR-Med, Inc. from Q4 2020 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
IR-Med, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2020 to Q2 2025.
  • IR-Med, Inc. Liabilities and Equity for the quarter ending June 30, 2025 was $175K, a 80.3% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)

IR-Med, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $175K -$712K -80.3% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $124K -$455K -78.6% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $251K -$748K -74.9% Dec 31, 2024 10-Q 2025-08-14
Q3 2024 $533K -$1.24M -69.9% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $887K -$1.74M -66.2% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $579K -$1.79M -75.6% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $999K -$2.3M -69.7% Dec 31, 2023 10-K 2025-04-04
Q3 2023 $1.77M -$2.35M -57% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.62M -$1.87M -41.6% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.37M -$38K -1.58% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $3.29M +$351K +11.9% Dec 31, 2022 10-K/A 2024-04-08
Q3 2022 $4.12M +$427K +11.6% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $4.49M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $2.41M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $2.94M +$853K +40.8% Dec 31, 2021 10-K/A 2023-05-11
Q3 2021 $3.7M Sep 30, 2021 10-Q 2021-11-15
Q4 2020 $2.09M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.